BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 1934005)

  • 1. Interferon-gamma C-terminal function: new working hypothesis. Heparan sulfate and heparin, new targets for IFN-gamma, protect, relax the cytokine and regulate its activity.
    Lortat-Jacob H; Grimaud JA
    Cell Mol Biol; 1991; 37(3):253-60. PubMed ID: 1934005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon-gamma binds to heparan sulfate by a cluster of amino acids located in the C-terminal part of the molecule.
    Lortat-Jacob H; Grimaud JA
    FEBS Lett; 1991 Mar; 280(1):152-4. PubMed ID: 1901275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The heparan sulfate binding sequence of interferon-gamma increased the on rate of the interferon-gamma-interferon-gamma receptor complex formation.
    Sadir R; Forest E; Lortat-Jacob H
    J Biol Chem; 1998 May; 273(18):10919-25. PubMed ID: 9556569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of heparin/heparan sulphate in the IFN-γ-led Arena.
    Xu K; Jin L
    Biochimie; 2020 Mar; 170():1-9. PubMed ID: 31794784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-gamma, an anti-fibrogenic cytokine which binds to heparan sulfate.
    Lortat-Jacob H; Esterre P; Grimaud JA
    Pathol Res Pract; 1994 Oct; 190(9-10):920-2. PubMed ID: 7899141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of interferon-gamma to heparan sulfate is restricted to the heparin-like domains and involves carboxylic--but not N-sulfated--groups.
    Lortat-Jacob H; Grimaud JA
    Biochim Biophys Acta; 1992 Sep; 1117(2):126-30. PubMed ID: 1525174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of interferon gamma by glycosaminoglycans: a strategy for localization and/or inhibition of its activity.
    Fernandez-Botran R; Yan J; Justus DE
    Cytokine; 1999 May; 11(5):313-25. PubMed ID: 10328871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-affinity binding of interferon-gamma to a basement membrane complex (matrigel).
    Lortat-Jacob H; Kleinman HK; Grimaud JA
    J Clin Invest; 1991 Mar; 87(3):878-83. PubMed ID: 1900310
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-receptor-mediated tissue localization of human interferon-gamma: role of heparan sulfate/heparin-like molecules.
    Lortat-Jacob H; Brisson C; Guerret S; Morel G
    Cytokine; 1996 Jul; 8(7):557-66. PubMed ID: 8891437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparan sulfate mimicry: a synthetic glycoconjugate that recognizes the heparin binding domain of interferon-gamma inhibits the cytokine activity.
    Sarrazin S; Bonnaffé D; Lubineau A; Lortat-Jacob H
    J Biol Chem; 2005 Nov; 280(45):37558-64. PubMed ID: 16155294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction of fibroblast growth factor-1 and related peptides with heparan sulfate and its oligosaccharides.
    Fromm JR; Hileman RE; Weiler JM; Linhardt RJ
    Arch Biochem Biophys; 1997 Oct; 346(2):252-62. PubMed ID: 9343372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neural cell adhesion molecule (NCAM) heparin binding domain binds to cell surface heparan sulfate proteoglycans.
    Kallapur SG; Akeson RA
    J Neurosci Res; 1992 Dec; 33(4):538-48. PubMed ID: 1484387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of lipoprotein lipase with heparin fragments and with heparan sulfate: stoichiometry, stabilization, and kinetics.
    Lookene A; Chevreuil O; Ostergaard P; Olivecrona G
    Biochemistry; 1996 Sep; 35(37):12155-63. PubMed ID: 8810923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon and heparan sulphate.
    Lortat-Jacob H
    Biochem Soc Trans; 2006 Jun; 34(Pt 3):461-4. PubMed ID: 16709188
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into the mechanism by which interferon-γ basic amino acid clusters mediate protein binding to heparan sulfate.
    Saesen E; Sarrazin S; Laguri C; Sadir R; Maurin D; Thomas A; Imberty A; Lortat-Jacob H
    J Am Chem Soc; 2013 Jun; 135(25):9384-90. PubMed ID: 23734709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular organization of the interferon gamma-binding domain in heparan sulphate.
    Lortat-Jacob H; Turnbull JE; Grimaud JA
    Biochem J; 1995 Sep; 310 ( Pt 2)(Pt 2):497-505. PubMed ID: 7654188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions of heparin/heparan sulfate with proteins: appraisal of structural factors and experimental approaches.
    Powell AK; Yates EA; Fernig DG; Turnbull JE
    Glycobiology; 2004 Apr; 14(4):17R-30R. PubMed ID: 14718374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heparin decreases the blood clearance of interferon-gamma and increases its activity by limiting the processing of its carboxyl-terminal sequence.
    Lortat-Jacob H; Baltzer F; Grimaud JA
    J Biol Chem; 1996 Jul; 271(27):16139-43. PubMed ID: 8663206
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparan sulfate fibroblast growth factor receptor complex: structure-function relationships.
    McKeehan WL; Kan M
    Mol Reprod Dev; 1994 Sep; 39(1):69-81; discusison 81-2. PubMed ID: 7999363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the heparin/heparan sulfate binding site of the natural cytotoxicity receptor NKp46.
    Zilka A; Landau G; Hershkovitz O; Bloushtain N; Bar-Ilan A; Benchetrit F; Fima E; van Kuppevelt TH; Gallagher JT; Elgavish S; Porgador A
    Biochemistry; 2005 Nov; 44(44):14477-85. PubMed ID: 16262248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.